Detects novel coronavirus in as little as 5 minutes.*
Leading molecular point-of-care (POC) platform in the United States, trusted by hospitals, physician offices and urgent care facilities nationwide
High-quality molecular technology targeting COVID-19 RdRp gene
Emergency Use Authorization (EUA) supports flexible near-patient testing environments
Direct sample types include:
ID NOW™ platform designed with POC in mind
SPEED — Positive result in as little as 5 minutes, negative results in 13 minutes.
Timely results enable healthcare professionals to make appropriate and more efficient treatment and infection control decisions.
TECHNOLOGY — ID NOW™ utilizes proven isothermal molecular technology in an intuitive platform, providing the fastest molecular results in the market.
EASE OF USE — Simplifying the test process
Designed for near-patient testing in a variety of environments**
Assay kit contains all necessary components for testing, including:
Room-temperature storage eliminates need for refrigeration
*ID NOW™ COVID-19 detects positive results in as a little as 5 minutes. Negative results detected in 13 minutes.
**Please see ID NOW Instrument user manual for additional operating environment requirements
